145 related articles for article (PubMed ID: 11106327)
1. A modified, optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma.
Kárpáti L; Penke B; Katona E; Balogh I; Vámosi G; Muszbek L
Clin Chem; 2000 Dec; 46(12):1946-55. PubMed ID: 11106327
[TBL] [Abstract][Full Text] [Related]
2. Kinetic determination of blood coagulation Factor XIII in plasma.
Muszbek L; Polgár J; Fésüs L
Clin Chem; 1985 Jan; 31(1):35-40. PubMed ID: 2856900
[TBL] [Abstract][Full Text] [Related]
3. A photometric assay for blood coagulation factor XIII.
Fickenscher K; Aab A; Stüber W
Thromb Haemost; 1991 May; 65(5):535-40. PubMed ID: 1871715
[TBL] [Abstract][Full Text] [Related]
4. Measurement of factor XIII activity in plasma.
Katona É; Pénzes K; Molnár É; Muszbek L
Clin Chem Lab Med; 2012 Feb; 50(7):1191-202. PubMed ID: 22850052
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Factor XIII.
Muszbek L; Katona É; Kerényi A
Methods Mol Biol; 2017; 1646():277-293. PubMed ID: 28804836
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a sensitive colorimetric FXIII incorporation assay. Effects of FXIII Val34Leu, plasma fibrinogen concentration and congenital FXIII deficiency.
Wilmer M; Rudin K; Kolde H; Poetzsch B; Lenz W; Moessmer G; Meili E; Egbring R; Gempeler-Messina P; Gempeler M; Bastian S; Kohler H
Thromb Res; 2001 Apr; 102(1):81-91. PubMed ID: 11323018
[TBL] [Abstract][Full Text] [Related]
7. Measurement of factor XIII (FXIII) activity by an automatic ammonia release assay using iodoacetamide blank-procedure: no more overestimation in the low activity range and better detection of severe FXIII deficiencies.
Cini M; Legnani C; Frascaro M; Pancani C; Cappelli C; Rodorigo G; Valdrè L; Cosmi B
Clin Chem Lab Med; 2016 May; 54(5):805-9. PubMed ID: 26457781
[TBL] [Abstract][Full Text] [Related]
8. A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma.
Oertel K; Hunfeld A; Specker E; Reiff C; Seitz R; Pasternack R; Dodt J
Anal Biochem; 2007 Aug; 367(2):152-8. PubMed ID: 17582378
[TBL] [Abstract][Full Text] [Related]
9. A photometric method for the dosage of factor XIII applied to the study of chronic hepatopathies.
Ballerini G; Gemmati D; Moratelli S; Morelli P; Serino ML
Thromb Res; 1995 Jun; 78(5):451-6. PubMed ID: 7660361
[TBL] [Abstract][Full Text] [Related]
10. Factor XIII Deficiency.
Karimi M; Bereczky Z; Cohan N; Muszbek L
Semin Thromb Hemost; 2009 Jun; 35(4):426-38. PubMed ID: 19598071
[TBL] [Abstract][Full Text] [Related]
11. Rapid determination of blood coagulation factor XIII activity using protein arrays for serodiagnosis of human plasma.
Kwon MH; Kong DH; Jung SH; Suh IB; Kim YM; Ha KS
Anal Chem; 2011 Mar; 83(6):2317-23. PubMed ID: 21323342
[TBL] [Abstract][Full Text] [Related]
12. [Condition setting for the measurement of blood coagulation factor XIII activity using a fully automated blood coagulation analyzer, COAGTRON-350].
Kanno N; Kaneko M; Tanabe K; Jyona M; Yokota H; Yatomi Y
Rinsho Byori; 2012 Dec; 60(12):1131-8. PubMed ID: 23427694
[TBL] [Abstract][Full Text] [Related]
13. Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement.
Pitkänen HH; Jouppila A; Lemponen M; Ilmakunnas M; Ahonen J; Lassila R
Thromb Res; 2017 Jan; 149():56-61. PubMed ID: 27902939
[TBL] [Abstract][Full Text] [Related]
14. Automation of a Factor XIII Activity Assay Utilizing a Plasma Blank Measurement.
Smock KJ; Moser KA
Methods Mol Biol; 2023; 2663():693-706. PubMed ID: 37204746
[TBL] [Abstract][Full Text] [Related]
15. Clinical Validation of an Automated Fluorogenic Factor XIII Activity Assay Based on Isopeptidase Activity.
Leitner M; Büchold C; Pasternack R; Binder NB; Moore GW
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498248
[TBL] [Abstract][Full Text] [Related]
16. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.
Jadhav MA; Goldsberry WN; Zink SE; Lamb KN; Simmons KE; Riposo CM; Anokhin BA; Maurer MC
Biochim Biophys Acta Proteins Proteom; 2017 Oct; 1865(10):1246-1254. PubMed ID: 28687225
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of a modified colorimetric solid-phase microassay for measuring the activity of cellular and plasma (Factor XIII) transglutaminases.
Thomas V; El Alaoui S; Massignon D; Clément S; Simonet F; Quash G
Biotechnol Appl Biochem; 2006 Mar; 43(Pt 3):171-9. PubMed ID: 16313237
[TBL] [Abstract][Full Text] [Related]
18. Quantification of coagulation factor XIII activity by a thio-NADH based assay using factor XIII immuno-depleted plasma as a diluent for calibration.
Kappel A; Stephan S; Christ G; Pechmann L; Duwe C; Fischer B; Hahn M; Althaus H; Ehm M; Schwarz H; Vitzthum F
Clin Chem Lab Med; 2010 Dec; 48(12):1739-43. PubMed ID: 20828366
[TBL] [Abstract][Full Text] [Related]
19. A highly sensitive chemiluminescence immunoassay for the measurement of coagulation factor XIII subunits and their complex in tears.
Orosz ZZ; Katona E; Facskó A; Berta A; Muszbek L
J Immunol Methods; 2010 Feb; 353(1-2):87-92. PubMed ID: 20079358
[TBL] [Abstract][Full Text] [Related]
20. Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit a antigen and transglutaminase activity.
Muszbek L; Adány R; Kávai M; Boda Z; Lopaciuk S
Thromb Haemost; 1988 Apr; 59(2):231-5. PubMed ID: 2898817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
